How have the shares performed?
Blonder Tongue Laboratories Inc. (BDR) saw downtrend of -4.41% in the recent trading with $1.30 being its most recent. The current price level -65.79% lower than the highest price of $3.80 marked by the stock while trading over the past 52-weeks, whereas it is 136.36% higher than the lowest price of $0.55 the company dropped to over past 52-weeks. The latest news story on BDR appeared in ACCESSWIRE under the title “Blonder Tongue Laboratories, Inc. to Host Earnings Call” on May-13-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -9.72% below one month high and is +22.64% above of the lowest during that time. Looking into the simple moving average, Blonder Tongue Laboratories Inc. (BDR)’s stock stands at a SMA-50 of $1.2190 while that of 5-day is reading $1.3360.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and BDR’s SMA-200 as of now is $1.2633.
Blonder Tongue Laboratories Inc. Earnings – What Happened With BDR
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. During the reported three-month period, company’s sales were $3.25 billion.
BDR – Blonder Tongue Laboratories Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 11.65 million. BDR does have institutional investors; and they hold 5.40% of the stock.
Blonder Tongue Laboratories Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 34 new insider purchases involving 32,854 shares. On the other hand, BDR declared 298,129 shares have been sold in 13 insider transactions over the past three months.
As on Mar 30, 2021, Tufton Capital Management was the top most holder in Blonder Tongue Laboratories Inc. (AMEX:BDR) with an ownership of 0.19 million shares of the company or 1.58% of the stake worth $0.28 million. The filing also reveals Citadel Advisors LLC as the second largest holder in the company with a control over 0.73% of the outstanding shares. Its stake is worth $0.13 million for having 87899.0 shares in hand.
Renaissance Technologies, LLC also came holding a key position in the company during the recent quarter and it now holds 0.68% of the outstanding shares. With this there are now 9 institutions which have possession in BDR’s shares.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Blonder Tongue Laboratories Inc. was 1.10 while posting a debt to equity ratio of 2.93. The count was 352.38 for long-term debt to equity ratio.
Technical Analysis of Blonder Tongue Laboratories Inc. (AMEX:BDR) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Blonder Tongue Laboratories Inc. (BDR), we notice that the stock’s 20-day average volume is at 708,735 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 614,564 shares. And to end with, BDR’s 100-day average volume are 792,051 shares.